
Biocept BIOC
Quartalsbericht 2023-Q2
hinzugefügt 14.08.2023
Biocept P/S 2011-2025 | BIOC
P/S Jährlich Biocept
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.229 | 0.675 | 2.53 | 1.16 | 1.62 | 1.83 | 4.37 | 38.5 | 63.2 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 63.2 | 0.229 | 12.7 |
P/S anderer Aktien in der Diagnostik & Forschung
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
1.72 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
0.1 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
13.5 | - | -61.36 % | $ 2.46 M | ||
|
Brainsway Ltd.
BWAY
|
8.09 | $ 19.06 | -1.6 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
6.87 | $ 20.31 | -5.8 % | $ 221 M | ||
|
Co-Diagnostics
CODX
|
5.13 | $ 0.23 | -4.17 % | $ 6.75 M | ||
|
Chembio Diagnostics
CEMI
|
0.254 | - | 0.22 % | $ 16.8 M | ||
|
Castle Biosciences
CSTL
|
2.14 | $ 39.2 | -0.49 % | $ 1.09 B | ||
|
Danaher Corporation
DHR
|
6.37 | $ 230.87 | 0.23 % | $ 169 B | ||
|
DarioHealth Corp.
DRIO
|
2.13 | $ 10.36 | 3.19 % | $ 294 M | ||
|
BioNano Genomics
BNGO
|
0.115 | $ 1.51 | -0.9 % | $ 1.92 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
5.71 | - | - | $ 562 M | ||
|
Exact Sciences Corporation
EXAS
|
3.38 | $ 101.86 | 0.28 % | $ 18.9 B | ||
|
DexCom
DXCM
|
13.5 | $ 67.65 | 0.12 % | $ 26.1 B | ||
|
Enzo Biochem
ENZ
|
0.0018 | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
1.65 | $ 26.63 | -0.34 % | $ 805 M | ||
|
Global Cord Blood Corporation
CO
|
0.196 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
3.48 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
1.36 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
2.9 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
2.77 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
2.47 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
1.86 | $ 19.19 | -1.49 % | $ 1.03 B | ||
|
Heska Corporation
HSKA
|
3.28 | - | - | $ 1.31 B | ||
|
Anixa Biosciences
ANIX
|
0.337 | $ 3.19 | -0.31 % | $ 102 K | ||
|
HTG Molecular Diagnostics
HTGM
|
0.469 | - | -20.0 % | $ 1.06 M | ||
|
IQVIA Holdings
IQV
|
2.31 | $ 227.26 | 0.15 % | $ 41.2 B | ||
|
Guardant Health
GH
|
7.91 | $ 100.93 | -1.99 % | $ 12.4 B | ||
|
Aspira Women's Health
AWH
|
5.55 | - | -6.19 % | $ 10.5 M | ||
|
Myriad Genetics
MYGN
|
1.16 | $ 6.32 | -2.55 % | $ 573 M | ||
|
ENDRA Life Sciences
NDRA
|
1.59 K | $ 4.75 | -4.81 % | $ 2.55 M | ||
|
Neogen Corporation
NEOG
|
1.14 | $ 7.2 | 0.98 % | $ 1.56 B | ||
|
National Research Corporation
NRC
|
6.79 | $ 18.95 | 1.55 % | $ 465 M | ||
|
Illumina
ILMN
|
3.75 | $ 134.56 | -0.29 % | $ 21.4 B | ||
|
Charles River Laboratories International
CRL
|
2.11 | $ 203.33 | -0.11 % | $ 10.4 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.93 | $ 175.36 | -0.34 % | $ 19.5 B | ||
|
Biodesix
BDSX
|
1.29 | $ 6.79 | -0.44 % | $ 880 M | ||
|
Motus GI Holdings
MOTS
|
3.1 | - | -34.28 % | $ 263 K | ||
|
Koninklijke Philips N.V.
PHG
|
1.8 | $ 27.26 | 0.57 % | $ 20 B | ||
|
Laboratory Corporation of America Holdings
LH
|
1.62 | $ 252.95 | -0.4 % | $ 21.2 B | ||
|
ICON Public Limited Company
ICLR
|
3.25 | $ 182.75 | -0.05 % | $ 15.1 B | ||
|
IDEXX Laboratories
IDXX
|
9.66 | $ 685.99 | -0.36 % | $ 56.6 B | ||
|
Lantheus Holdings
LNTH
|
4.21 | $ 67.0 | 0.43 % | $ 4.64 B | ||
|
Personalis
PSNL
|
3 | $ 8.01 | -1.6 % | $ 475 M | ||
|
Mettler-Toledo International
MTD
|
7.72 | $ 1 419.41 | -0.06 % | $ 30.1 B | ||
|
Agilent Technologies
A
|
6.64 | $ 138.09 | -0.22 % | $ 42 B | ||
|
Quidel Corporation
QDEL
|
6.36 | $ 29.27 | -0.12 % | $ 1.23 B | ||
|
Biomerica
BMRA
|
1.35 | $ 2.6 | -3.7 % | $ 5.97 M |